A leading private equity player

The power of and

Companies must face multiple challenges to innovate, grow and adapt to a rapidly changing environment. It has been Andera Partners’ mission for over 20 years to help companies and their management achieve strong and sustainable growth. Our conviction, at the heart of our commitment, our partnership and our way to work with entrepreneurs, is that to grow and develop, it is essential to have the right partners and enjoy working together. The Power of And thus becomes Andera Partners’ signature that relays our conviction.

Our commitments Our investments

4.1 billion under management

300 companies supported in over 20 years

115 professionals

Our Activities

Andera Partners is an asset management firm specialising in Private Equity. We draw on our expertise in various areas to provide a range of well-defined investment strategies. Our goal is to provide bespoke solutions to meet the challenges faced by leaders and their business models.

Our activities

Our Latest News

Below you will find all the latest news on Andera Partners, its teams and its investments.

26.07.2024 - andera Life Sciences - Press releases

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Boar…

Combined Shape

25.07.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences

Combined Shape

25.07.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upc…

Combined Shape

15.07.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca

Combined Shape

09.07.2024 - andera Life Sciences - Press releases

Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom

Combined Shape

02.07.2024 - Andera Partners - Sustainability - Publications

2023 Sustainability Report

Combined Shape

27.06.2024 - andera Expansion/Croissance - Press releases

Spengler Group takes on a European dimension with the acquisition of German manufacturer Luxamed

Combined Shape

14.03.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the d…

Combined Shape

14.03.2024 - andera Life Sciences - Press releases

Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca

Combined Shape

28.02.2024 - andera Infra - Press releases

Andera Partners raises a final amount of € 233 million for Andera Smart Infra 1, its first fund dedi…

Combined Shape

21.02.2024 - andera Life Sciences - Press releases

MMI Raises $110 Million in Series C Financing

Combined Shape

12.02.2024 - andera Life Sciences - Recruitment

Internship Offer – Andera Life Sciences

12.02.2024 - Andera Partners - Press releases

2023 Report – After a record year of investments and exits, Andera Partners sets a target of 7…

Combined Shape

24.01.2024 - andera Expansion/Croissance - Press releases

Meogroup initiates a new development cycle with the support of Andera Partners

Combined Shape

23.01.2024 - Andera Partners - Press releases

Andera Partners welcomes Sophie ELKRIEF as Business Development Partner

Combined Shape
Our Latest News